VagiVital long term vision is to enable women to manage their intimate health with clinically proven and trusted self-care products. All from diagnosing, to treating and preventing intimate health conditions.

Therefor it is with great excitement that Peptonic today announces that the first of VagiVital products now enter the US market. VagiVital AktivGel for the treatment of vaginal dryness and VagiVital Moisturizing V Cleanser feature a complete regimen for daily vaginal health that will be available for all women in the USA.

• As women in US tend to be more concerned about vaginal hormone treatments compared to for example women in the Nordics, we are excited about the coming phase in the development of Peptonic internationally, says Erik Sundquist, CEO of Peptonic Medical.

Initially VagiVital products will be available through its own web shop https://us.vagivital.com/ and on Amazon from this week. This way Peptonic will learn the US VagiVital consumer persona, which is of essence for further expansion into additional partnerships and distribution channels on and offline.

• The buildup model is, with some local adoptions, similar to the one we have successfully used in Sweden and we are excited to now be under way in the US market, says Mikael Svensson, General Manager Peptonic US.

The expansion into US of the VagiVital range of products underscores Peptonics commitment to women's health globally.